Viewing Study NCT03587805


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-03-01 @ 5:54 PM
Study NCT ID: NCT03587805
Status: COMPLETED
Last Update Posted: 2025-03-11
First Post: 2018-07-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Sponsor: LEO Pharma
Organization: